Study of the Efficacy and Safety of Topical Ivermectin + Iota-Carrageenan in the Prophylaxis against COVID-19 in Health Personnel

  title={Study of the Efficacy and Safety of Topical Ivermectin + Iota-Carrageenan in the Prophylaxis against COVID-19 in Health Personnel},
  author={Carvallo H{\'e}ctor and H Gonzalez R Roberto and Alkis James Psaltis and C Onuora Veronica},
Introduction The severe acute respiratory syndrome-coronavirus-2 (SARSCoV-2) pandemic has had devastating health and socioeconomic implications worldwide. Epidemiologic data indicate that SARS-CoV is spread by respiratory droplets and contact [1]. Corresponding Author: Hirsch Roberto, University of Buenos Aires, Argentina Received date: November 09, 2020; Accepted date: November 16, 2020; Published date: November 17, 2020. DOI: Abstract The severe acute… 

Figures and Tables from this paper

Intensive Treatment With Ivermectin and Iota-Carrageenan as Pre-exposure Prophylaxis for COVID-19 in Health Care Workers From Tucuman, Argentina

Experimental evidence for the prophylactic use of ivermectin associated with iota-carrageenan in health workers is presented, presenting experimental evidence to prevent transmission and improvement in the treatment in both observational and randomized trials.

A review on drug repurposing in COVID-19: from antiviral drugs to herbal alternatives

11 repurposing drugs, their positive and negative health implications, along with traditional herbal alternatives, that harvest strong potential in efficient treatments options against COVID-19, with small or no significant side effects are summarized.

Repositioning Ivermectin for Covid-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replication

Ivermectin reduces the risk of death from COVID-19 – a rapid review and meta-analysis in support of the recommendation of the Front Line COVID-19 Critical Care Alliance

The evidence on ivermectin “demonstrates a strong signal of therapeutic efficacy” and it is recommended that iverMectin is adopted globally and systematically for the prophylaxis and treatment of COVID-19.

Antiparasitic Drugs against SARS-CoV-2: A Comprehensive Literature Survey

The (controversial) journey of these old antiparasitic drugs to combat the human infection caused by the novel coronavirus SARS-CoV-2 is reviewed.

Repurposing the drug, ivermectin, in COVID-19: toxicological points of view

Based on the current dose recommendation, ivermectin appears to be safe with minimum side effects, however, serious questions remain about the effectiveness of this drug in the treatment of patients with COVID-19.

Ivermectin: A Controversial Focal Point during the COVID-19 Pandemic

This review compiled the available information regarding the various effects attributed to Ivermectin and considers the proposal unfeasible because the therapeutic doses proposed to achieve this effect cannot be achieved.

Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines

Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin, and the apparent safety and low cost suggest that iverMectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally.

Cluster Randomised Trials - Ivermectin Repurposing For COVID-19 Treatment Of Outpatients With Mild Disease In Primary Health Care Centers

Treatment with ivermectin in outpatients care with mild disease of COVID-19 managed to slightly reduce PPS and improved the clinical state to obtain outpatient discharge, even in the presence of comorbidities.



Detection of 2019-nCoV in Saliva and Characterization of Oral Symptoms in COVID-19 Patients

Saliva may be a new source of diagnostic specimens for critically-ill patients, since it can be easily collected without any invasive procedures and demonstrates the possibility of 2019-nCoV infection of the salivary glands.

Clinical and immunological features of severe and moderate coronavirus disease 2019

The SARS-CoV-2 infection may affect primarily T lymphocytes, particularly CD4+ and CD8+ T cells, resulting in a decrease in numbers as well as IFN-γ production by CD4+, which may be of importance because of their correlation with disease severity in COVID-19.

[Efficacy of ivermectin in the treatment of children parasitized by Strongyloides stercoralis].

A 200 microg/kg/d ivermectin dose was an adequate therapeutic regimen in the treatment of uncomplicated strongyloidiasis in children in a small village of Amazonian Colombia.

Cutaneous manifestations in COVID‐19: a first perspective

  • S. Recalcati
  • Medicine
    Journal of the European Academy of Dermatology and Venereology : JEADV
  • 2020
By Feb 15, COVID-19 has rapidly spread throughout China and across the world, until a pandemic condition was announced by March 112 .

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

ACE2 is abundantly present in humans in the epithelia of the lung and small intestine, which might provide possible routes of entry for the SARS‐CoV.

Ivermectin distribution in the plasma and tissues of patients infected with Onchocerca volvulus

In healthy volunteers, the plasma ivermectin distribution was similar to that in patients, and both groups showed a tendency for a second rise in plasma concentration of the drug suggestive of enterohepatic recirculation, whilst values for skin, nodular tissues, and worms were comparable.

A Review of Salivary Diagnostics and Its Potential Implication in Detection of Covid-19

Saliva is an exocrine secretion produced from the salivary glands and has numerous functions, such as cleansing and protection of the oral cavity, antimicrobial effects and aids in digestion, which has an immense potential as a diagnostic fluid and offers an edge over other biological fluids.

Carrageenan nasal spray in virus confirmed common cold: individual patient data analysis of two randomized controlled trials

Administration of carrageenan nasal spray in children as well as in adults suffering from virus-confirmed common cold reduced duration of disease, increased viral clearance and reduced relapses of symptoms.